Herpes Simplex Virus Type I Stromal Keratitis

1

Review clinical trials related to Herpes Simplex Virus Type I Stromal Keratitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

This study aims to compare the clinical efficacy and safety of BD111 injection in combination with standard therapy vs. standard therapy in herpes simplex virus type I stromal keratitis (HSK), providing preliminary confirmation of the clinical effectiveness of BD111 in combination with standard therapy.

Participants needed: 40
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai BDgene Co., Ltd.Updated: May 18, 2025Locations: 1
Eligibility criteria

Aged 18 to 70 years old; [+11]

Active ocular infection caused by other pathogens in the target eye or the fello... [+21]